View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View Generic ICR - OIRA Conclusion
OMB Control No:
0925-0642
ICR Reference No:
202002-0925-002
Status:
Historical Active
Previous ICR Reference No:
201905-0925-001
Agency/Subagency:
HHS/NIH
Agency Tracking No:
Title:
Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI)
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
03/20/2020
Retrieve Notice of Action (NOA)
Date Received in OIRA:
02/19/2020
Terms of Clearance:
Previous terms continue: OMB approves this collection for a period of three years. To request approval of information collections under this generic approval, the agency must do the following: 1) Unless an agency is using multiple modes of collection (e.g., paper forms and electronic submissions), provide a Generic Clearance Submission Template for each Instrument; 2) If the agency is using multiple modes of collection (e.g., paper forms and electronic submissions), the same Generic Clearance Submission Template may be used for both instruments; 3) each Generic Clearance Submission Template must be uploaded as a Supplementary document using a naming convention that allows the public to identify the associated instrument; 4) submit no more than five Generic Submission Templates with each request.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
03/31/2023
36 Months From Approved
05/31/2020
Responses
100,800
0
49,500
Time Burden (Hours)
28,011
0
26,751
Cost Burden (Dollars)
0
0
0
Abstract:
Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI), seeks to obtain OMB approval to extend the generic clearance to collect qualitative feedback on our service delivery for an additional three (3) years. This generic has provided information about the National Cancer Institute’s customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. It has also allowed feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance provides useful information but it does not yield data that can be generalized to the overall population.
Authorizing Statute(s):
EO: EO 12862 Name/Subject of EO: SETTING CUSTOMER SERVICE STANDARDS
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
84 FR 66209
12/03/2019
30-day Notice:
Federal Register Citation:
Citation Date:
85 FR 8309
02/13/2020
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
84
IC Title
Form No.
Form Name
"Preferences for Emails from CBIIT" Survey (NCI)
1
CBIIT email feedback survey
2020 Dietary Primer Assessment and Feedback (NCI)
1
Dietary Primer survey
2020 NCI Community Oncology Research Program (NCORP) Virtual Annual Meeting Feedback (NCI)
1
NCORP Meeting Feedback questions
2021 DCEG, NCI Committee of Scientists Survey (NCI)
1
2021 COS survey
2021 New Grantee Workshop Survey (NCI)
2, 1
Day 1 survey
,
Day 2 survey
2022 DCEG Survey- Woman Scientist Advisors (WSA) (NCI)
1
DCEG WSA survey
2022 NCORP Annual Meeting Post-Event Survey (NCI)
1
2022 NCORP Annual Post Survey
: 2020 Trans-NCI-NIH Conference: International Perspectives on Integrative Medicine for Cancer Prevention and Cancer Patient Management Feedback Survey (NCI)
1
2020 Trans NCI-NIH Conference Feedback survey
Advancing Rapid Cycle Research to Improve Cancer-Related Care (NCI)
1
Rapid Cyle Survey
Animal Models for Cancer Interception and Precision Prevention Virtual Workshop Feedback (NCI)
1
Animal Models feedback survey
Associate Member Council of the NCI Cohort Consortium – Member Feedback (NCI)
1
AMC Member survey
Aurora User Survey (NCI)
1, 2, 3
Video script 1-4 and survey Part 1
,
video script 5-7 and survey Part 2
,
Video script 8-14 and survey Part 3
Automated Self-Administered 24-Hour (ASA24) Dietary Assessment Tool Customer Satisfaction Survey (NCI)
1
screenshot survey
Automated Self-Administered 24-Hour (ASA24) Dietary Assessment Tool Researcher Website Post-Launch (NCI)
1
ASA24 Research Website feedback
CBIIT Service Now Customer Satisfaction Surveys (NCI)
1
ServiceNow Survey
CRCHD Mentored Mock Review – Participant Feedback (NCI)
1
MMR 2022 survey
CRDC 2022 Spring Meeting Survey (NCI)
1
CRDC Spring meeting feedback
CTSU Delegation of Tasks Log (DTL) Feedback Survey (NCI)
1, 2
DTL or CI survey
,
Other Site Staff DTL survey
Cancer Moonshot Seminar Series – Participant Feedback (NCI)
1
CMSS survey
Cancer Prevention Fellowship Program (CPFP) Fellows Research Meeting (FRM) Speaker Feedback Form (NCI)
1
FRM Fellows Feedback form
Cancer Research Training Travel Awards (CRTTA) Program Survey (NCI/CGH)
1
CRTTA survey
Center for Cancer Training (CCT) Annual Courses and Workshops Satisfaction Survey (NCI)
1
CCT course feedback survey
Cluster Randomized Trial Designs in Cancer Care Delivery Research Survey (NCI)
1
Virtual Short Course survey on Cluster Randomized
Cohort Consortium Webinar Series Survey Form (NCI)
1
Cohort Consortium Webinar Survey Post-Event
Committee ON NCI-Extramural Communication Tools and Support (CONNECTS) Feedback (NCI)
1
Connect survey
Confluence Uses Survey (NCI)
1
Confluence Use survey
Containers and Workflows Interest Group (CWIG) Webinar Series Feedback Survey (NCI)
1
CWIG screenshots
Customer Satisfaction Survey for CBIIT Town Hall and NCI Orientation. (NCI)
1
CBIIT Town Hall and NCI Orientation survey
Customer Satisfaction Surveys for CBIIT's Newsletter and Intranet (NCI)
1
CBIIT Newsletter and Intranet survey
DCEG "Emerging Approaches for Tumor Analyses in Epidemiological Studies" workshop 2022 Feedback (NCI)
1
survey screenshot Emerging ApproachesEpi Course feedback
DCEG Bioinformatics Task-Force - Support & Capacity Survey (NCI)
1
DCEG Bioinformatics Task force survey
DCEG Bioinformatics Task-Force - Support & Capacity Survey (NCI)
1
DCEG BIO survey
DCEG Fellows Feedback Survey 2022 (NCI)
1
2022 DCEG Fellows Feedback survey
DCEG Fellows Survey 2021 (NCI)
1
Fellows survey screenshot
Data Terminology Content Satisfaction Survey (NCI)
1
CDISC survey
Division of Cancer Control and Population Sciences (DCCPS) Fellows Survey (NCI)
1
2020 DCCPS Fellows Survey
Division of Cancer Control and Population Sciences (DCCPS) Future of Cancer Health Economics Research Conference Feedback (NCI)
1
Cancer Health Economics Survey form
Division of Cancer Control and Population Sciences (DCCPS) Webinar Survey Form (NCI)
1
General DCCPS Webinar Survey form
Drug Development Topics of Interest to NCI Developmental Therapeutics Program (NCI)
1
DTP Survey
Early Investigator Advancement Program (EIAP) Application Process Surveys (NCI)
2, 1
EIAP Application
,
EIAP AppReview
Early Investigator Advancement Program (EIAP) Scholar and Mentor Program Satisfaction Surveys (NCI)
2, 1
EIAP Mentor Satisfaction survey
,
EIAP Scholar Satisfaction survey
Early Investigator Advancement Program (EIAP) Specific Aims Workshop and One-on-One Meetings Survey (NCI)
1
EIAP 2022 SURVEY
Explore On Site (EXPOSE) Alumni- Customer Satisfaction Survey (NCI)
1
EXPOSE Alumni Survey
Explore On Site (EXPOSE) Pre-and Post- Customer Satisfaction Survey (NCI)
1, 2
EXPOSE post survey
,
EXPOSE pre-survey
Feedback on NIH Common Fund's High-Risk, High-Reward Research Symposium (NIH/OD)
1
HRHR survey
Fellows' Cancer Health Disparities Interest Group (CHDIG) Survey (NCI)
1
Survey for Cancer Health Disparities Interest Group
Fellows' Cancer Health Disparities Interest Group (CHDIG) Survey (NCI)
1
CHDIG survey
Focus Group Discussion on Barriers to Clinical Trial Participation (NCI)
1
Focus Group Guide on Barriers to CT Participation
I-SCORE 2022 Feedback Survey (NCI)
1
I-SCORE 2022 feedback form
IT Knowledge Survey (NCI)
1, 2, 3, 4, 5
Survey 1 Communication and Collaboration Tools
,
Survey 2 Software
,
Survey 3 Backing up Data
,
Survey 4 Remote Access & Account Management
,
Survey 5 Troubleshooting
IT Training Program Assessment Questionnaire (NCI)
1
Training Questionnaire
Implementation Science Consortium in Cancer Survey Form (NCI)
1
ISCC survey form
Intramural Continuing Umbrella of Research Experiences (iCURE) Program Application Process – Applicant and PI Feedback (NCI)
2, 1
PI Feedback survey
,
Applicant feedback survey
Mentored Mock Review – Participant Feedback (NCI)
1
MMR survey
NCI Division of Cancer Biology (DCB) New Grantee Workshop – Customer Satisfaction Survey (NCI)
1
DCB New Grantee survey
NCI F99/K00 Awardees Survey (NCI)
1
NCI F99 and K00 Awardees survey
NCI OSFM Customer Satisfaction Shuttle Survey (NCI)
1
Shuttle survey
NCI Technology Transfer Center Surveys (NCI)
1, 2, 3
Intramural Researchers
,
Industry Partners
,
TT Delivers
NCI Workplace Flexibilities Assessment (NCI)
1
Workplace Assessment screenshots
NCORP Annual Meeting Feedback (NCI)
1
2021 NCORP Meeting Feedback
NCORP CCDR Seminar Series survey (NCI)
1
2021 NCORP Seminar survey
NCORP Electronic Medical Record (EMR) Survey (NCI)
1
EMR screenshot
New Interdisciplinary Research on Cancer and Aging P30 Cancer Support Grant Supplement Awardee Meeting Survey (NCI)
1
Cancer and Aging P30 survey
Partnerships to Advance Cancer Health Equity (PACHE) Program Meeting – Participant Feedback (NCI)
1
PACHE 2021 feedback screenshots
Perspectives on Cancer and Aging: The Arti Hurria Memorial Webinar Series (NCI)
1
Cancer & Aging Poll screenshot
Physician Data Query (PDQ) Partner Survey (NCI)
1
PDQ Partner survey
Post Division of Cancer Epidemiology & Genetics (DCEG) Using RStudio with Box Workshop Survey (NCI)
1
survey screenshot
Post Event Challenges and Opportunities for Addressing Financial Hardship as Part of Cancer Care Delivery 2022 Feedback (HDRP) (NCI)
1
post event feedback survey
Post Event Survey - Addressing Social Risks in Cancer Care Delivery Workshop (NCI)
1
ASR Workshop feedback survey
Principles of Pediatric Clinical Pharmacology and Therapeutics Course – Continuing Medical Education Customer Satisfaction Questionnaire (NICHD)
1
Ped Clin CME survey
Professional Development Workshop (PDW) and Mentored Mock Review (MMR) – Participant Feedback (NCI)
1
PDW & MMR Feedback survey
Questionnaire to assess attendee satisfaction with the NIEHS Impact of Environmental Exposures on the Microbiome and Human Health workshop (NIEHS)
1
Microbiome and Human Health workshop survey
SeroNet Investigators Meeting 2022 Participant Feedback Survey (NCI)
1
SeroNet Investigators Meeting Feedback
Survey to Assess NCI's Center for Cancer Training (CCT) Trainee Experience (NCI)
1
CCT survey
Technical Assistance Workshop (TAW) – Participant Feedback (NCI)
1
TAW 2020 Survey screenshots
The 10th Annual Symposium on Global Cancer Research Survey (NCI)
1
ASGCR screenshots
The 9th Annual Global Cancer Research Symposium Feedback Survey (NCI)
1
2021 ASGCR survey
The Early Career Investigator Day (ECID) Participant Survey (NCI)
1
ECID survey
Trans-NCI Extramural Awareness Group (TEAG) Forum Survey (NCI)
1
TEAG SURVEY
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop Feedback on Immunomodulatory Agents Survey (NCI)
1
TACPAD Feedback survey
Translational Advances in Cancer Prevention Agent Development Meeting Survey (NCI)
1
Millery Survey
ULACNet Annual Meeting Feedback Survey (NCI)
1, 1, 1, 1
ULACNet English version
,
ULACNet Spanish version
,
ULACNet Portuguese version
,
ULACNet French version
Voice of the Customer (VOC) Surveys for NCI's Cancer.gov and other NCI content (NCI)
1
VOC survey
Webpage Survey Questions on Select NCCIH Website Content Pages (NCCIH)
1
screenshot NCCIH website Page survey
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
100,800
49,500
0
51,300
0
0
Annual Time Burden (Hours)
28,011
26,751
0
1,260
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
This is an Extension of a currently approved submission. There are no substantive changes to this submission, however the burden hours have increased by 420 hours. NCI, through various outreach meetings and discussions have increased the visibility of the PRA program. This outreach has led to an increase in requests and is projected to continue as more departments, offices, and centers become aware of the process . This is the difference of the previously approved 8,917 minus the proposed, 9,337. The total number of respondents has increased by 17,100 from 10,000 to 27,100. This increase is to account for the increased survey activities that are planned
Annual Cost to Federal Government:
$20,532
Does this IC contain surveys, censuses, or employ statistical methods?
Yes
Part B of Supporting Statement
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Tawanda Abdelmouti 240 276-5530 ta401@nih.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
02/19/2020